Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
15.36
+0.26 (1.72%)
At close: Feb 6, 2026, 4:00 PM EST
14.98
-0.38 (-2.47%)
After-hours: Feb 6, 2026, 6:03 PM EST
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $841.45 million as of February 6, 2026. Its market cap has increased by 29.18% in one year.
Market Cap
841.45M
Enterprise Value
553.26M
1-Year Change
29.18%
Ranking
Category
Stock Price
$15.36
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $841.45M, a decrease of -9.69%. That is a compound annual growth rate of -7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 841.45M | -8.73% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 902.41M |
| Arvinas | 865.74M |
| BridgeBio Oncology Therapeutics | 855.88M |
| Annexon | 854.09M |
| Xencor | 829.08M |
| Valneva SE | 826.79M |
| Maravai LifeSciences Holdings | 802.92M |
| Omeros | 796.21M |